Astragaloside II suppresses colorectal cancer progression by upregulating LGALS4 expression
{{output}}
This study investigates the inhibitory effect of astragaloside II (AGS-II) on colorectal cancer (CRC) progression and elucidates the underlying mechanism involving LGALS4. The effects of AGS-II on proliferation, migration, and apoptosis of CRC cells were asses... ...
